Try our beta test site
Trial record 1 of 1 for:    NCT01684397
Previous Study | Return to List | Next Study

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2017 by Roswell Park Cancer Institute
Sponsor:
Collaborators:
National Cancer Institute (NCI)
GlaxoSmithKline
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01684397
First received: August 24, 2012
Last updated: March 7, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 5, 2019
  Estimated Primary Completion Date: February 5, 2018 (Final data collection date for primary outcome measure)